Upregulation Of Glt8d2 Confers Cddp Resistance In Ovarian Cancer In

Upregulation of GLT8D2 confers CDDP resistance in ovarian cancer in ...
Upregulation of GLT8D2 confers CDDP resistance in ovarian cancer in ...
Upregulation of FAM46A conferred ovarian cancer to CDDP resistance in ...
Upregulation of FAM46A conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Upregulation of GOLPH3L conferred ovarian cancer to CDDP resistance in ...
Inhibition of GLT8D2 sensitize ovarian cancer to CDDP treatment in in ...
Inhibition of GLT8D2 sensitize ovarian cancer to CDDP treatment in in ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets
Hypoxia induces CDDP resistance in ovarian cancer cells. a Expression ...
Hypoxia induces CDDP resistance in ovarian cancer cells. a Expression ...
| Up-regulation of CCND2 Induces CDDP resistance in Cervical Cancer ...
| Up-regulation of CCND2 Induces CDDP resistance in Cervical Cancer ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Mechanism of reduction-induced CDDP resistance in ovarian cells via the ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted ...
GLT8D2 is overexpression in human ovarian cancer with chemoresistance ...
GLT8D2 is overexpression in human ovarian cancer with chemoresistance ...
GLT8D2 is overexpression in human ovarian cancer with chemoresistance ...
GLT8D2 is overexpression in human ovarian cancer with chemoresistance ...
Upregulation of GLT8D2 activates the FGFR/PI3K signalling axis in ...
Upregulation of GLT8D2 activates the FGFR/PI3K signalling axis in ...
Redox regulation of the CDDP resistance of ovarian cancer cells is ...
Redox regulation of the CDDP resistance of ovarian cancer cells is ...
In vivo activity of 2 and cDDP in human ovarian carcinoma (A2780) in ...
In vivo activity of 2 and cDDP in human ovarian carcinoma (A2780) in ...
Akt is a determinant of chemoresistance in human ovarian cancer cells ...
Akt is a determinant of chemoresistance in human ovarian cancer cells ...
CDX2 confers ferroptosis resistance in stage II-III colon cancer via ...
CDX2 confers ferroptosis resistance in stage II-III colon cancer via ...
Involvement of PPM1D in the regulation of CDDP sensitivity in ovarian ...
Involvement of PPM1D in the regulation of CDDP sensitivity in ovarian ...
Mechanism of reversing drug resistance in vitro. a CDDP retention after ...
Mechanism of reversing drug resistance in vitro. a CDDP retention after ...
cDDP and metformin treatment in ovarian cancer PDXs. Antitumor activity ...
cDDP and metformin treatment in ovarian cancer PDXs. Antitumor activity ...
Autophagy promotes DDP resistance in ovarian cancer cells. (a) CCK-8 ...
Autophagy promotes DDP resistance in ovarian cancer cells. (a) CCK-8 ...
Overexpression of NR2F6 confers cisplatin resistance on ovarian cancer ...
Overexpression of NR2F6 confers cisplatin resistance on ovarian cancer ...
A schematic mechanism of ERS in CDDP-induced ovarian damage. Exogenous ...
A schematic mechanism of ERS in CDDP-induced ovarian damage. Exogenous ...
Redox status affects the drug resistance of ovarian cancer cells. (A ...
Redox status affects the drug resistance of ovarian cancer cells. (A ...
Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are ...
Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are ...
Glutamine starvation reduces the GSH level and CDDP resistance in ...
Glutamine starvation reduces the GSH level and CDDP resistance in ...
Δ Np63 α and AKT1 levels affect CDDP resistance in sensitive/resistance ...
Δ Np63 α and AKT1 levels affect CDDP resistance in sensitive/resistance ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Generation of ovarian cancer cells resistant to CDDP and PTX. (A ...
Unlocking the potential of immunotherapy in platinum-resistant ovarian ...
Unlocking the potential of immunotherapy in platinum-resistant ovarian ...
Glutamine starvation reduces the GSH level and CDDP resistance in ...
Glutamine starvation reduces the GSH level and CDDP resistance in ...
Potentiation of CDDP antitumor effect induced by ganetespib in parental ...
Potentiation of CDDP antitumor effect induced by ganetespib in parental ...
Upregulation of the percentage of CD8+ T cell in the tumor tissue by ...
Upregulation of the percentage of CD8+ T cell in the tumor tissue by ...
Altered glutamine metabolism in platinum resistant ovarian cancer ...
Altered glutamine metabolism in platinum resistant ovarian cancer ...

Loading image details...

Source
Dimensions